Euroopan unioni -
suomi -
EMA (European Medicines Agency)
nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immunoseerumit ja immunoglobuliinit, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immunoseerumit ja immunoglobuliinit, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
trientine waymade 200 mg kapseli, kova
waymade b.v. - trientine dihydrochloride - kapseli, kova - 200 mg - trientiini
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
hetlioz
vanda pharmaceuticals netherlands b.v. - tasimelteon - unihäiriöt, sirkadian rytmi - psyykenlääkkeiden - hetlioz on tarkoitettu 24-tunnin nukahtamishäiriön (ei-24) hoitoon täysin sokeilla aikuisilla.